Details of the Drug Reposition

General Information of This Drug (ID: DMSUQFJ)

Drug Name
SBI-087   DMSUQFJ
Synonyms PF-05230895

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Multiple sclerosis DISB2WZI 8A40 Phase 2 [1]
Rheumatoid arthritis DISTSB4J FA20 Phase 2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01008852) Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis. U.S. National Institutes of Health.